Good news for sufferers of MS.
MMJ RECEIVES APPROVAL TO CONDUCT PHASE 2 CLINICAL TRIAL FOR TREATMENT OF MULTIPLE SCLEROSIS SYMPTOMS Highlights: • 100%-owned subsidiary, PhytoTech Therapeutics, receives Clinical Site and Ministry of Health approvals to conduct Phase 2 clinical trial of PTL201 • Phase 2 clinical trial is aimed at measuring safety and efficacy of the PTL201 capsules in treating spasticity related symptoms in multiple sclerosis (MS) patients • Phase 2 clinical trial is double-blind, randomised, placebo-controlled, parallel-group study in 70 MS patients • Success of Phase 2 will be a major step towards commercial development of the PTL201 drug for treatment of MS debilitating symptoms • Phase 2 clinical trial of PTL101 to treat refractory epilepsy in paediatric patients is proceeding as planned
Ann: MMJ Receives Approval to Conduct MS Phase 2 Clinical Trials, page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HGV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.622M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 291807 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 26115 | 1 |
View Market Depth
| Last trade - 10.04am 25/07/2024 (20 minute delay) ? |
| HGV (ASX) Chart |
Day chart unavailable